Kanika Kamal

ORCID: 0000-0002-0907-1310
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acne and Rosacea Treatments and Effects
  • LGBTQ Health, Identity, and Policy
  • melanin and skin pigmentation
  • Dermatologic Treatments and Research
  • Dermatology and Skin Diseases
  • Inflammatory Bowel Disease
  • Hair Growth and Disorders
  • Skin Protection and Aging
  • Psoriasis: Treatment and Pathogenesis
  • Microscopic Colitis
  • Hidradenitis Suppurativa and Treatments
  • Sex and Gender in Healthcare
  • Diverticular Disease and Complications
  • Autoimmune and Inflammatory Disorders
  • Feminist Theory and Gender Studies
  • Dermatological diseases and infestations
  • Retinoids in leukemia and cellular processes
  • Allergic Rhinitis and Sensitization
  • Urticaria and Related Conditions
  • Chemotherapy-related skin toxicity
  • Medicine and Dermatology Studies History
  • Colorectal and Anal Carcinomas
  • Cutaneous Melanoma Detection and Management
  • RNA regulation and disease
  • Music Therapy and Health

Brigham and Women's Hospital
2020-2025

Harvard University
2020-2025

Kaiser Permanente
2025

Massachusetts General Hospital
2023-2024

Harvard University Press
2023

Concert Pharmaceuticals (United States)
2023

AbbVie (United States)
2023

Eli Lilly (United States)
2023

CS Diagnostics
2023

Boehringer Ingelheim (Germany)
2023

Abstract Background and Aims Vedolizumab is an anti-α4β7 biologic approved for ulcerative colitis [UC] Crohn’s disease [CD]. We aimed to examine the association of maintenance vedolizumab concentrations with remission. Methods performed a cross-sectional multi-centre study inflammatory bowel [IBD] patients on vedolizumab. A homogeneous mobility shift assay [HMSA] was used determine trough serum anti-drug antibodies [ATVs]. The primary outcome corticosteroid-free clinical biochemical...

10.1093/ecco-jcc/jjz041 article EN Journal of Crohn s and Colitis 2019-02-13

Masculinizing gender-affirming hormonal therapy is associated with the development of acne. While isotretinoin a highly effective acne treatment, little known about its effectiveness and safety among transgender gender-diverse individuals receiving therapy.

10.1001/jamadermatol.2024.1420 article EN JAMA Dermatology 2024-05-29

Summary Background Race, ethnicity and socio‐economic status impact clinical outcomes in inflammatory bowel disease (IBD) patients. However, their on disability has not been studied. Aim To determine the association between race, factors with IBD, using validated IBD index (IBD‐DI). Methods Ambulatory patients were enrolled at five academic centres participating New York Crohn's Colitis Organization. We assessed IBD‐DI, collected data. Factors associated moderate‐to‐severe (IBD‐DI score >...

10.1111/apt.15107 article EN Alimentary Pharmacology & Therapeutics 2019-01-20

Importance Research on the prevalence of barriers to care among sexual and gender minority (SGM) patients with chronic inflammatory skin diseases (CISDs) in US is limited. Objective To compare cost noncost SGM non-SGM CISDs analyze based status race ethnicity. Design, Setting, Participants A cross-sectional study health access utilization survey data collected by National Institutes Health’s All Us Program between May 31, 2017, July 1, 2022, was conducted. were adults aged 18 years or older...

10.1001/jamadermatol.2023.3328 article EN JAMA Dermatology 2023-09-27

Despite societal, legal, and cultural improvements in their well-being, sexual gender minority (SGM) people the United States still face substantial physical mental health disparities that are exacerbated by physician stigma lack of training. Although there have been efforts at medical schools nationwide to address these interweave SGM education into existing preclerkship courses, opportunities practice related clinical skills during clerkship years remain largely elective. Furthermore,...

10.1097/acm.0000000000005240 article EN Academic Medicine 2023-04-12

Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...

10.1001/jamadermatol.2021.5190 article EN JAMA Dermatology 2022-02-23

BACKGROUND Physician malpractice lawsuits are climbing, and the reasons underlying litigation against dermatologists unclear. OBJECTIVE To determine patients pursue or dermatology practices. MATERIALS AND METHODS A retrospective analysis of all state federal cases between 2011 2022 was performed after a query using “Dermatology” “dermatologist” as search terms on 2 national legal data repositories. RESULTS The authors identified total 48 (37 11 federal) in which practicing dermatologist...

10.1097/dss.0000000000004142 article EN Dermatologic Surgery 2024-02-28

Few studies have considered the diverse mental and physical health impacts of scarring among transgender gender (TGD) patients after medically necessary gender-affirming surgery (GAS). For some TGD patients, post-GAS may exacerbate dysphoria. others, it is a representation authenticity. The dearth research or validated instruments capturing diversity priorities concerns pre- hinders providers' ability to deliver optimal clinical care throughout gender-affirmation process impedes progress for...

10.1089/lgbt.2022.0308 article EN LGBT Health 2023-02-16

Abstract Generalized pustular psoriasis (GPP) is a form of that distinguished by recurring or persistent outbreaks non‐acral primary sterile pustules. These eruptions can occur with without systemic inflammation. Various factors, such as medications, stress and viral infection, have been identified potential triggers for GPP flares. While several cases detailed GPP‐like in the setting coronavirus disease 2019 (COVID‐19) few explored interplay between infection biologic use development GPP....

10.1111/exd.14889 article EN Experimental Dermatology 2023-07-14
Coming Soon ...